PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'From the Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands (A.H.J.D.).\', \'Division of Nephrology and Hypertension, University of Miami Miller School of Medicine, FL (M.E.).\', \'Division of Nephrology/Hypertension, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL (D.B.).\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1161/HYPERTENSIONAHA.120.15082
?:hasPublicationType
?:journal
  • Hypertension (Dallas, Tex. : 1979)
is ?:pmid of
?:pmid
?:pmid
  • 32208987
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all